DEKK-TEC, Inc.

Quick facts

Phase 2 pipeline

• 4-Demethyl-4-cholestryloxycarbonylpenclomedine · Oncology
  4-Demethyl-4-cholestryloxycarbonylpenclomedine is a chemotherapy medication that works by inhibiting the enzyme topoisomerase II.
• A-007 · Diabetes
  A-007 is a small molecule that targets the SGLT2 receptor.
• DM-CHOC-PEN

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• DEKK-TEC, Inc. portfolio CI brief
• DEKK-TEC, Inc. pipeline updates RSS